VisMederi is a globally competent, science-driven Research and Service Company partnering with corporations and the pharmaceutical industry to accelerate licensure of safer, more effective drugs.
Backed by strong resources and international expertise, we deliver clinical and pre-clinical sample testing for the evaluation of vaccines, monoclonal antibodies, and antiviral therapeutics across all stages of drug development. Our core business span serological and cell-mediated immunity assays to evaluate the immunogenicity of vaccines, through to creation and validation of bioanalytical methods, and optimization of experimental protocols for the assessment of biologicals and therapeutic molecules. The tests conducted within VisMederi’s facilities are routinely validated and standardized to ensure robust, high quality protocols applicable to both clinical trial and research settings.